Preclinical Imaging Market Size Estimated to Reach $983.6 Million by 2025

10/30/2020 4:12:33 PM

(MENAFN- iCrowdNewsWire) The global Preclinical Imaging (In-VIVO) Market based on modality type has Micro-Ultrasound, Micro Magnetic Resonance imaging (MRI), Micro Computed Tomography (CT), Optical Imaging, Positron Emission Tomography (PET), Single Photo Emission Computed Tomography (SPECT), Photo-acoustic Imaging systems, Magnetic Particle Imaging (MPI) systems. Micro Ultrasound has a dominant role during the year 2019 and is set to have the fastest growth during the forecast period 2020-2025, owing to the wide ranges of application and most effective to make researches on the small animal models. The other modalities like Micro-CT and Optical Imaging are also set to have the fastest growth owing to the increase in usage of these modalities and the advancement of the latest technologies in these segments.

Request for Sample of the Report @ [To enable links contact MENAFN]

Report Price: $ 4500 (Single User License)

By Application - Segment Analysis

The Application segment of Preclinical Imaging (In-VIVO) Market has Drug discovery, Bio-distribution, Cancer cell detection, Bio-markers, Research and development. The research and development section has a dominant role in the year 2019 and is set have the fastest growth during the forecast period 2020-2025 owing to the increased usage of the modalities for the research and development of different types of drugs and treatments. The increase in chronic diseases and the adoption of the preclinical in-vivo imaging in cancer cell detection and drug discovery is boosting the market.

By Geography - Segment Analysis

The global Preclinical Imaging (In-VIVO) Market by geography had the dominant share in North America, in terms of revenue in 2019. North America holds the largest market share owing to the increase in installation of the modalities for research and development of treatment process and drug development. The Europe is also set to grow during the forecast period 2020-2025 owing to the increase in new technology and increased funding by the government and private sectors for the research. Favorable growth and increased chronic diseases among the people and having the best infrastructure for research and development are some of the factors supporting the growth of this market around the globe.

Drivers – Preclinical Imaging (In-VIVO) Market

Increased usage of Preclinical Imaging in different sectors

The demand for preclinical in-vivo imaging modalities in different fields like research and development, drug discovery, cancer cell detection and other are boosting the market of preclinical in-vivo imaging. The increase in funding by the private and public sectors are also driving the market. Adaption of new technologies and acquisitions made by different market players in different players of the world are supporting the growth of the market.

Talk to one of our sales representative about the full report by providing your details in the link below:

[To enable links contact MENAFN]

Challenges – Preclinical Imaging (In-VIVO) Market

High cost of modalities

The high price of modalities and the cost of the research processes are limiting many of the institutes to adopt this preclinical in-vivo imaging process. Limited application of different modalities is another factor challenging market growth.

Preclinical Imaging (In-VIVO) Industry outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Preclinical Imaging (In-VIVO) Market. Key companies of this market are PerkinElmer, Inc., Siemens A.G, Bruker Corporation, FUJIFILM Holdings Corporation, Mediso Ltd., MILabs B.V., Agilent Technologies, Miltenyi Biotech GmbH, Aspect Imaging, TriFoil Imaging, and others.

Acquisitions/Product Launches:

In February 2017, FUJIFILM VisualSonics Inc, announced the launch of new Vevo LAZR-X, which uses high-frequency ultrasound and photoacoustic imaging techniques together for the animal research application.
In February 2019, Bruker announced the new Skyscan 1273 benchtop 3D x-ray microscope based on micro-CT technology, this is used for the non-destructive 3D imaging, covering a variety of industrial and scientific application.

Key Takeaways

Geographically, North America's Preclinical Imaging (In-VIVO) Market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the high usage of different modalities in research and development.

Advancement in new technologies and increased usage of different types of modalities together for better and fast results is boosting the market.

Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Preclinical Imaging Market report.

Increase in chronic diseases like cancer, cardiovascular, neurological disorders and other diseases are set to increase the growth of the preclinical imaging market during the forecast period 2020-2025.

Related Report :

A. Optical Imaging Market

[To enable links contact MENAFN]

B. Nuclear Imaging Market

[To enable links contact MENAFN]

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to to discuss more about our consulting services.